CJC-1295 (No DAC) / Ipamorelin

Growth Hormone Peptide

CJC-1295 (No DAC) / Ipamorelin

CJC-1295 No DAC / Ipamorelin Blend (CJC-1295 No DAC + Ipamorelin) is a multi-peptide formulation developed for advanced investigation into growth hormone secretagogue activity, hypothalamic-pituitary axis signaling, and…

1
$59.99
Most Popular
Best Value
Est. delivery Jun 5 - Jun 9
Free shipment protection
Secure checkout
We accept: Visa Mastercard American Express
Free shipping on orders over $200
Damage protection on every order
Secure checkout 256-bit SSL
Certificate of Analysis
Tested for Identification, Purity, Mass, Endotoxins, Sterility, and Heavy Metals
LATEST SELECTED DOSAGE
99.50%
PURITY
Variant CJC-1295 (No DAC) / Ipamorelin 10MG
Lot # CJCIPA-2605-A02
Labeled 10mg
Actual 10.11mg
Tested May 5, 2026
Compound Information
Pharmaceutical Specifications
Molecular Profile
What Is CJC-1295 (No DAC) / Ipamorelin?
TypeSynthetic peptide blend
CAS Number863288-34-0 / 170851-70-4
Molecular FormulaC₁₄₉H₂₄₆N₄₄O₄₂S / C₃₈H₄₉N₉O₅
Molecular Weight3,367.97 / 711.87 g/mol
Amino Acids30 / 5
Storage Requirements
Stability Information
Freeze for storage Refrigerate after reconstitution Protect from light
Lyophilized (powder)
-20°C  ·  -20°C
Reconstituted
2-8°C  ·  ~30 days
Research
Sources & References
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ENDOCRINE SOCIETY/OXFORD)
Prolonged Stimulation of Growth Hormone and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults
2006  ·  DOI: 10.1210/jc.2005-1536
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA
View Source
ENDOCRINOLOGY (ENDOCRINE SOCIETY/OXFORD)
Human GRF(1-29)-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog
2005  ·  DOI: 10.1210/en.2004-1286
Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP
View Source
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ENDOCRINE SOCIETY/OXFORD)
Pulsatile Secretion of Growth Hormone Persists During Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog
2006  ·  DOI: 10.1210/jc.2006-1702
Ionescu M, Frohman LA
View Source
EUROPEAN JOURNAL OF ENDOCRINOLOGY (BIOSCIENTIFICA/ESE)
Ipamorelin, the First Selective Growth Hormone Secretagogue
1998  ·  DOI: 10.1530/eje.0.1390552
Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH
View Source
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (SPRINGER)
Prospective, Randomized, Controlled, Proof-of-Concept Study of the Ghrelin Mimetic Ipamorelin for the Management of Postoperative Ileus in Bowel Resection Patients
2014  ·  DOI: 10.1007/s00384-014-2030-8
Beck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group
View Source
EUROPEAN JOURNAL OF ENDOCRINOLOGY (BIOSCIENTIFICA/ESE)
The GH Secretagogues Ipamorelin and GH-Releasing Peptide-6 Increase Bone Mineral Content in Adult Female Rats
2000  ·  DOI: 10.1530/eje.0.1420461
Svensson J, Lall S, Dickson SL, Bengtsson BA, Rømer J, Ahnfelt-Rønne I, Ohlsson C, Jansson JO
View Source
TRANSLATIONAL ANDROLOGY AND UROLOGY (AME PUBLISHING)
Beyond the Androgen Receptor: The Role of Growth Hormone Secretagogues in the Modern Management of Body Composition in Hypogonadal Males
2020  ·  DOI: 10.21037/tau.2019.11.30
Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI
View Source
ANNALS OF INTERNAL MEDICINE (ACP)
Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized Trial
2008  ·  DOI: 10.7326/0003-4819-149-9-200811040-00003
Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO
View Source
SEXUAL MEDICINE REVIEWS (ELSEVIER)
The Safety and Efficacy of Growth Hormone Secretagogues
2018  ·  DOI: 10.1016/j.sxmr.2017.02.004
Sigalos JT, Pastuszak AW
View Source
JCSM RAPID COMMUNICATIONS (WILEY)
Growth Hormone Secretagogues: History, Mechanism of Action, and Clinical Development
2020  ·  DOI: 10.1002/rco2.9
Ishida J, Saitoh M, Doehner W, von Haehling S, Anker SD, Springer J, Anker MS
View Source

Growth Hormone Peptide

CJC-1295 No DAC / Ipamorelin Blend (CJC-1295 No DAC + Ipamorelin) is a multi-peptide formulation developed for advanced investigation into growth hormone secretagogue activity, hypothalamic-pituitary axis signaling, and pulsatile GH release modulation.

Additional information

Size:

10MG

You May Also Like